Single-centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides

Br J Dermatol. 2022 Feb;186(2):363-365. doi: 10.1111/bjd.20757. Epub 2021 Dec 7.

Authors

D Falkenhain-López¹, J Fulgencio-Barbarin¹, M Puerta-Peña¹, J Montero-Menárguez¹, A Sánchez-Velázquez¹, P L Ortiz-Romero^{1

2}

Affiliations

¹ Dermatology Department of the Hospital Universitario 12 de Octubre, Madrid, Spain.
² Institute i+12, Medical School, University Complutense, Madrid, Spain.

PMID: 34528240
DOI: 10.1111/bjd.20757

No abstract available

Publication types

Letter

MeSH terms

Doxorubicin / analogs & derivatives
Humans
Mycosis Fungoides* / drug therapy
Polyethylene Glycols / therapeutic use
Skin Neoplasms* / drug therapy

Substances

liposomal doxorubicin
Polyethylene Glycols
Doxorubicin